[1] 段宇, 冯尚勇, 刘超, 等. 江苏省六市、县亚临床甲状腺功能亢进症患病状况调查[J]. 中华预防医学杂志, 2008, 42(9):698-699. [2] 段宇, 刘超, 冯尚勇, 等. 江苏地区甲状腺功能减退症流行现状调查[J]. 中华内分泌代谢杂志, 2008, 24(3):275-277. [3] 冯尚勇, 刘超, 刘晓云, 等. 江苏高淳、楚州地区社区人群甲状腺结节流行特征研究[J]. 南京医科大学学报(自然科学版), 2006, 26(8):717-720. [4] LI Y, TENG D, BA J, et al. Efficacy and safety of long-term universal salt iodization on thyroid disorders: epidemiological evidence from 31 provinces of mainland China[J]. Thyroid, 2020, 30(4):568-579. [5] DENG Y, LI H, WANG M, et al. Global burden of thyroid cancer from 1990 to 2017[J]. JAMA Netw Open, 2020, 3(6): e208759. [6] GOICHOT B, RAVEROT V, KLEIN M, et al. Management of thyroid dysfunctions in the elderly. French Endocrine Society consensus statement 2019. Long version[J]. Ann Endocrinol: Paris, 2020, 81(2/3): 89-100. |